Menu

MIT Provost Steps Down

Chris Kaiser, a molecular biologist, leaves his administrative post to return to research and teaching.

Sep 18, 2013
Erin Weeks

WIKIMEDIA, JOHN PHELANAfter a little more than a year in the position, Chris Kaiser announced this week (September 16) that he will step down as provost of the Massachusetts Institute of Technology (MIT) in late October. Kaiser will return to “the rich and exciting intellectual life of an MIT faculty member,” he said.

Prior to serving as provost, Kaiser chaired the university’s biology department for eight years. He turned down an opportunity to lead the National Institute of General Medical Sciences in 2012 before accepting the administrative role at MIT.

“Since taking on the role of provost, Chris has served by my side through a challenging period for MIT,” President L. Rafael Reif wrote in an e-mail to the MIT community. Among other things, the university made headlines in the past year for its role in the prosecution of the late Aaron Schwartz.

Kaiser said that he plans to remain active in community engagement surrounding the Schwartz case and the university’s online education initiatives.

“As provost . . . I have been an enthusiastic cheerleader as the revolution in online learning sweeps across MIT,” he wrote. “But administration and cheerleading are not the same as doing. I am eager to return to the classroom and to actively participate in the development of new educational tools.”

January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb

Marketplace

Sponsored Product Updates

FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 million ($125 million upfront payment and $135 million of milestones).  QIAGEN has announced plans for a global launch in 2020 of a new series of digital PCR platforms that utilize the advanced dPCR technology developed by FORMULATRIX combined with QIAGEN’s expertise in assay development and automation.
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
With this application note from Taconic, learn about the power that the CRISPR/Cas system has to revolutionize the field of custom mouse model generation!
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
This webinar, from Crown Bioscience, presents a unique continuum of translational dysmetabolic platforms that more closely mimic human disease. Learn about using next-generation rodent and spontaneously diabetic non-human primate models to accurately model human-relevant disease progression and complications related to obesity and diabetes here!
BiochemAR: an augmented reality app for easy visualization of virtual 3D molecular models
BiochemAR: an augmented reality app for easy visualization of virtual 3D molecular models
Have you played Pokemon Go? Then you've used Augmented Reality (AR) technology! AR technology holds substantial promise and potential for providing a low-cost, easy to use digital platform for the manipulation of virtual 3D objects, including 3D models of biological macromolecules.